Dergiler / Turkish Journal of Medical Sciences / 2002 / Cilt: 32 - Sayı: 2

The relation between low-density lipoprotein (LDL) oxidation and hemodialysis with respect to membrane types: Protective effects of vitamin E-bonded membrane

Sayfa
93–100
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Improving LDL resistance to oxidation by using a vitamin E-bonded membrane appears to be an attractive alternative to prevent accelerated oxidative processes in hemodialysis patients.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Plasma total antioxidant (TAO) levels, LDL (low density lipoprotein), antioxidant defense potential (AOP) and the resistance to oxidation of LDL fractions were studied in chronic hemodialysis patients.
📊
Temel Bulgular & Veri:The assay principle of TAO was based on the suppression of ABTS+ radical cation (2,2'-Azino-di- [3-ethylbenzthiazoline sulfonate]) by the sample.
💡
Sonuç & Katkı:Improving LDL resistance to oxidation by using a vitamin E-bonded membrane appears to be an attractive alternative to prevent accelerated oxidative processes in hemodialysis patients.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Plasma total antioxidant (TAO) levels, LDL (low density lipoprotein), antioxidant defense potential (AOP) and the resistance to oxidation of LDL fractions were studied in chronic hemodialysis patients. The differences with respect to dialyzer membrane types before and after hemodialysis were also assessed. After isolation of LDL from plasma by precipitation, AOP was measured based on the determination of TBARS (thiobarbituric acid reactive substance), and resistance to oxidation was assessed by the metal-catalyzed peroxidation of LDL followed by the determination of the values of the peroxidation product malondialdehide (MDA) before and after peroxidation. The assay principle of TAO was based on the suppression of ABTS+ radical cation (2,2'-Azino-di- [3-ethylbenzthiazoline sulfonate]) by the sample. AOP and the resistance to oxidation of LDL were expressed as 1/nmol/ ml.h. Plasma TAO levels of patients (n=22) were significantly lower than those of the control group (n=20). In the patient group, the decrease in TAO levels was also significant and continued to the end of the single dialysis session. The rate of decrease was similar in the two types of conventional membranes used (polysulfone and hemophan). The antioxidant defense potential of LDL significantly decreased after hemodialysis with the polysulfone type dialyzer but resistance to oxidation values of LDL showed no difference. When the same group of patients were hemodialyzed with a vitamin E bonded membrane no difference was observed in the AOP of LDL, but resistance to oxidation of the LDL fraction significantly increased during the hemodialysis session. The results suggest that the vitamin E-bonded dialysis membrane strengthens the LDL antioxidant defense potential and protects the LDL from oxidation. In conclusion, the decreased antioxidant capacity in these patients may be attributed to several factors such as elimination via the dialyzer of enzymatic or nonenzymatic antioxidants or deformation of these compounds by the increased oxidant stress. Improving LDL resistance to oxidation by using a vitamin E-bonded membrane appears to be an attractive alternative to prevent accelerated oxidative processes in hemodialysis patients.

🔖

Bu Makaleye Atıf Yap

DEMİRTAŞ, S., AKBAY, A., KARACA, L., NERGİSOĞLU, G. (2022). The relation between low-density lipoprotein (LDL) oxidation and hemodialysis with respect to membrane types: Protective effects of vitamin E-bonded membrane. Turkish Journal of Medical Sciences, Cilt: 32 - Sayı: 2, 93–100. https://ajindex.com/articles/612191

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Jungers P, Massy ZA, Nguyen-Khoa T, Fumeron C et al.: Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: A prospective study. Nephrol Dial Transplant; 12: 2597- 2602, 1997
  2. London GM, DrŸeke TB: Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int: 51: 1678-1695, 1997
  3. Reaven PD, Witzum JL. The role of oxidation of LDL in atherogenesis. Endocrinologist; 5: 44-45, 1995
  4. Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr; 57 (suppl): 715S-725,1993
  5. Giardini O, Taccone-Gallucci M, Lubrano R et al.: Evidence of red blood cell membrane lipid peroxidation in hemodialysis patients. Nephron; 36: 235-237, 1984
  6. Kuroda M, Asaka S, Tofuku Y, Takeda R: Serum antioxidant activity in uremic patients. Nephron; 41: 293-298, 1985
  7. Ritz E, Deppisch R, Stier E, Hansch G: Atherogenesis and cardiac death: Are they related to dialysis procedure and biocompatibility? Nephrol Dial Transplant, 9 (Suppl 2): 165-172, 1994
  8. Maggi E, Bellazzi R, Gazo A, Seccia M, Bellomo G: Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int; 46: 869-876, 1994
  9. Holvoet P, Donck J, Landeloos M et al.: Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure. Thromb Haemost, 76: 663-669, 1996
  10. Schiecke G, Gwinner W, Radermaker J, Bahlmann J, Lonnemann G: Long-term effects of vitamin E-bonded dialsis membrane on mononuclear cell activation, MDA generation and endothelial function in ESRD patents; in Ronco C, La Greca G (eds): Vitamin EBonded Membrane. A Further Step in Dialysis Optimization. Contrib Nephrol. Basel, Karger, vol 127, 244-251, 1999
  11. Vlassara H: Serum advanced glycosylation and products: A new class of uremic toxins. Blood Purif; 12: 54- 59, 1994
  12. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa et al.: Advanced glycosilation protein products as a novel marker of oxidative stress in uremia. Kidney Int; 49: 1304- 1313, 1996
  13. Maggi E, Belazzi R, Falaschi F, Frattoni A, Peranni G et al.: Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis? Kidney Int; 45: 876- 883, 1994
  14. Vieland H, Seidel D. A simple specific method for precipitation of LDL. Journal of Lipid Research, 24; 904-909, 1983
  15. Dasgupta A, Zdunek T. Invitro lipid peroxidation of human serum